Hemodynamics, fluids & transfusion

Interaction Between Platelet and Fibrinogen on Clot Strength in Healthy Patients

J Cardiothorac Vasc AnesthPublished Prospective study

Authors' conclusion

In healthy patients, a PLT of 60 × 109/L was associated with normal clot strength (TEG-MA ≥53 mm), and there was little change in clot strength with PLT >90 × 109/L.

Study context

Population
Healthy volunteers without a history of coagulation abnormalities
Outcome
PLT vs TEG-MA
Methodological detailsin vitro hemodilution, single-centre
  • In vitro hemodilution
  • Single-centre

Main finding

As reported in the abstract

Correlation PLT and thromboelastography maximum amplitude (TEG-MA) (univariate), r
0.88; p < 0.0001
Biphasic relationship: linear below PLT 90 × 109/L, plateau above 100 × 109/L
p = 0.001
ROC: PLT associated with TEG-MA of 53.0 mm
60 × 109/L

Observational data: associations, not effects.

Further findings

Fibrinogen vs TEG-MA

Correlation fibrinogen and TEG-MA (univariate), r
0.70; p = 0.003
Linear relationship between fibrinogen (190-474 mg/dL) and TEG-MA (53-76 mm)
P = 0.0007

PLT × fibrinogen product vs TEG-MA

Correlation of product with TEG-MA, r (vs PLT r = 0.86, fibrinogen r = 0.71)
0.91
ROC: PLT × fibrinogen associated with TEG-MA of 55 mm
16,720

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Interaction Between Platelet and Fibrinogen on Clot Strength in Healthy Patients. J Cardiothorac Vasc Anesth. Published 20 February 2023. doi:10.1053/j.jvca.2023.02.022

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.